Insider Trading November 19, 2026 02:01 AM

Astera Labs Accounting Chief Offloads $7,230 in Stock to Cover Taxes

Germaine Cota's sale of 35 shares was tied to RSU vesting, not a discretionary trade, as the company's stock trades at $216.75 with mixed performance.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
ALAB

Astera Labs Chief Accounting Officer Germaine Cota sold 35 shares for $7,230 on November 16, 2026, to satisfy tax withholding obligations from vesting restricted stock units. The sale, executed at prices between $201.895 and $209.6586, was automatic under the company's sell-to-cover policy. Following the transaction, Cota directly holds 26,505 shares, including 100 acquired under the employee stock purchase plan. Astera Labs' stock, currently at $216.75, has risen 52.63% over the past year but fallen 11.26% over six months. The company recently reported strong third-quarter results with adjusted EPS of $1.32 on revenue of $584.9 million, surpassing estimates. Analysts have responded with mixed ratings and price target adjustments.

Astera Labs Accounting Chief Offloads $7,230 in Stock to Cover Taxes
ALAB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Germaine Cota's sale of 35 shares for $7,230 was an automatic transaction to cover taxes on vesting RSUs, not a discretionary trade, leaving her with 26,505 directly held shares.
  • Astera Labs reported strong Q3 2026 results with adjusted EPS of $1.32 on revenue of $584.9 million, beating estimates, and its Scorpio AI fabric line surpassed a $1 billion annualized revenue run rate.
  • Analyst reactions were mixed: Northland upgraded to Outperform, while Needham and UBS lowered price targets but maintained or adjusted ratings, reflecting valuation concerns in the AI sector.

Germaine Cota, Chief Accounting Officer and Vice President of Finance at Astera Labs, Inc. (NASDAQ:ALAB), disposed of 35 shares of the company's common stock on November 16, 2026, generating proceeds of $7,230. The shares were sold at prices ranging from $201.895 to $209.6586 per share.

The transaction was not a discretionary trade by Cota. Instead, it was executed to fulfill tax withholding requirements associated with the vesting and settlement of previously granted restricted stock units. Astera Labs has elected a mandatory 'sell to cover' policy for such tax obligations, meaning the sale was automatic and required by the company's procedures.

Following the sale, Cota directly holds 26,505 shares of Astera Labs common stock. This figure includes 100 shares that were acquired on November 13, 2026, through the Astera Labs, Inc. 2024 Employee Stock Purchase Plan.

Astera Labs' stock is currently trading at $216.75. Over the past year, the shares have appreciated 52.63%, but they have declined 11.26% over the last six months. According to InvestingPro analysis, the company appears slightly overvalued at current levels, though 19 analysts have recently revised their earnings estimates upward. The platform provides comprehensive analysis with additional ProTips and detailed financial metrics for investors seeking deeper insights.

In other recent developments, Astera Labs reported stronger-than-expected third-quarter 2026 results. The company posted adjusted earnings of $1.32 per share on revenue of $584.9 million, surpassing Wall Street forecasts of $1.19 per share and $550.8 million, respectively. Revenue grew 49% from the previous quarter and 154% from the same period last year.

The company also noted that its Scorpio AI fabric line exceeded a $1 billion annualized revenue run rate, underscoring growing demand for its AI infrastructure products. Following these results, Northland upgraded Astera Labs' stock rating to Outperform, citing the strong quarter and raised guidance. Needham maintained a Buy rating but reduced its price target to $300, pointing to valuation compression in the AI sector despite improved estimates for the company. UBS also lowered its price target to $290 while keeping a Neutral rating, citing similar valuation concerns but raising revenue and earnings estimates for future years.

These recent developments reflect a dynamic period for Astera Labs as it navigates the evolving market landscape.

Risks

  • The stock's 11.26% decline over the past six months and analyst concerns about valuation compression in the AI sector could signal further volatility.
  • Despite strong quarterly results, price target reductions from Needham and UBS suggest that market expectations for AI-related stocks may be recalibrating, potentially impacting Astera Labs' share performance.

More from Insider Trading

FRP Holdings Director John D. Baker II Increases Stake with $96,349 Purchase Nov 19, 2026 Rhythm Pharmaceuticals Director Offloads $1.1 Million in Stock Nov 19, 2026 Cricut Accounting Chief Offloads $87,000 in Stock as Shares Hover Near 52-Week High Nov 19, 2026 VSE Corp CEO John Cuomo Offloads $338,964 in Stock Under Pre-Arranged Plan Nov 19, 2026 Morningstar's Mansueto Offloads $1.8 Million in Shares Near 52-Week High Nov 19, 2026